德康医疗 DXCM 深 沪
等待开盘 08-08 09:30:00 美东时间
76.40
0.000
0.00%
华盛通- 最 高77.95
- 今 开77.12
- 成交量 308.39万股
- 最 低 75.59
- 昨 收 76.40
- 总市值 299.49亿
- 52周最高 93.25
- 市盈率 静 53.65
- 换手率 0.79%
- 52周最低 57.52
- 委 比 -76.88%
- 总股本 3.92亿
- 历史最高 164.863
- 量 比 0.49
- 振 幅 3.09%
- 历史最低 1.6875
- 每 手 1
- 风险率 7.53%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Insulet Peer Tandem Diabetes Underwhelming Earnings, Dull Outlook Drags Stock
Tandem Diabetes shares fall after a deeper loss, lower guidance, and a device recall tied to 700 adverse events and 59 injuries.
今天 01:50
Insulet Lifts Annual Forecast On Increased Adoption For Insulin Pump Omnipod 5
Insulet beats Q2 estimates with strong Omnipod growth and lifts 2025 revenue outlook on rising adoption and expanding global customer base.
今天 01:08
Garmin announces collaborations with leading brands for Garmin Marathon Series
Companies will bring exciting activations to the expo, course and finish line festival OLATHE, Kan., Aug. 5, 2025 /PRNewswire/ -- Garmin (NYSE: GRMN) today announced Brooks, Dexcom, Maurten,...
08-05 19:03
Forecasting The Future: 11 Analyst Projections For DexCom
DexCom (NASDAQ:DXCM) underwent analysis by 11 analysts in the last quarter, rev...
08-01 06:00
美股三大指数收跌 Meta涨超11% 微软涨4%
道指收跌0.74%，标普500指数跌0.37%，纳斯达克综合指数微跌。保健板块跌2.9%，房地产板块跌1.7%，原材料、金融、能源、可选消费、科技板块至多跌约...
08-01 04:02
纳斯达克100指数转跌，日内稍早曾涨1%
成分股Arm控股跌13.3%，德康医疗跌8.3%，高通跌7.6%，应用材料跌5.3%，阿斯麦ADR跌3%。美股科技七巨头中，Meta目前涨11.6%，微软涨4...
08-01 01:29
Dexcom Announces Leadership Transition with New CEO
Dexcom ( ($DXCM) ) just unveiled an update. Dexcom announced a leadership trans...
07-31 04:54
DexCom shares are trading lower following Q2 reported financial results.
DexCom shares are trading lower following Q2 reported financial results.
07-31 04:36
Dexcom Announces Promotion Of Jake Leach To CEO, Board Of Directors Effective Jan. 1, 2026
"Today's announcement of Jake's transition to the role of chief executive officer reflects the Board's comprehensive succession planning and their confidence in Jake's leadership throughout his tenure. We are confident
07-31 04:04
DexCom Raises FY2025 Sales Guidance from $4.60B to $4.60B-$4.63B vs $4.62B Est
DexCom (NASDAQ:DXCM) raises FY2025 sales outlook from $4.60 billion to $4.60 billion-$4.63 billion vs $4.62 billion estimate.
07-31 04:03
